title: MALT lymphoma and Kaposi sarcoma in an HIV-negative patient.
abstract: A 77-year-old caucasian man presented on March 2005 with important epigastric pain without any other significant history of gastritis. Patient refers a history of cutaneous Kaposi's sarcoma (KS) treated since 1974 with surgical excision or oncovorin topical injection. He underwent endoscopic evaluation showing a 1.5-cm ulcerated area at the gastric angulus, associated with edematous and erythematous nodular mucosa (Fig. 1).
authors: Aurora
authors: A
authors: Mirabile
authors: Liliana
authors: L
authors: Devizzi
authors: Alessandro M
authors: AM
authors: Gianni
authors: Antonello
authors: A
authors: Cabras
authors: Antonino
authors: A
authors: Carbone
mesh_terms: D000368:Aged; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D005756:Gastritis / Q000150:complications* / Q000188:drug therapy; D018023:HIV Seronegativity; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy; D016480:Helicobacter pylori / Q000302:isolation & purification; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D008297:Male; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D012074:Remission Induction; D012514:Sarcoma, Kaposi / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D012878:Skin Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000821:virology; D013276:Stomach Ulcer / Q000209:etiology* / Q000382:microbiology; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000900:Anti-Bacterial Agents; D018906:Antineoplastic Agents, Alkylating; D000972:Antineoplastic Agents, Phytogenic; D054328:Proton Pump Inhibitors; D002699:Chlorambucil; D014750:Vincristine; D014747:Vinblastine; D000658:Amoxicillin; D003520:Cyclophosphamide; D017291:Clarithromycin; D011241:Prednisone